Skip to main content
Equibles
IQV logo

IQV · Iqvia Holdings Inc. · Metrics

Track IQV — free

Use IQV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IQV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$277.92 -0.40 (-0.14%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$46.45B
Shares
166.90M
Volume · Oct 23 350.2K Avg daily vol (3M) 1.48M

IQV metrics

107 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$278.32
Market cap
$46.45B

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
+3.0%
Price change (3M)
+34.2%
Price change (6M)
+73.2%
Price change (YTD)
+23.5%
Price change (1Y)
+27.8%
Trailing year
Price change (5Y)
+8.3%
52-week high
$278.32
52-week low
$156.66
Change from 52-week high
+0.0%
Change from 52-week low
+77.7%
Annualized volatility
40.2%
Annualized volatility (3M)
39.0%
Beta
0.7
RSI (14D)
64.7
Price vs SMA 50
+6.0%
Price vs SMA 200
+33.4%
Avg volume (3M)
1.48M
Relative volume
1.0
Average dollar volume
$377.68M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
166.90M

Valuation

12 metrics
P / E (TTM)
34.6
Trailing earnings · reciprocal yield 2.9%
PEG ratio
—
EV / revenue
3.5×
reciprocal yield 28.3%
EV / EBITDA
17.8×
reciprocal yield 5.6%
EV / EBIT
27.3×
reciprocal yield 3.7%
P / sales
2.7×
reciprocal yield 36.8%
P / book
7.5
reciprocal yield 13.4%
FCF yield
4.7%
TTM · current market cap
Buyback yield
2.5%
P / FCF
21.1
reciprocal yield 4.7%
P / operating cash flow
16.4
reciprocal yield 6.1%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
28.2×
reciprocal yield 3.5%
P / E historical average (5Y)
35.2×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
3.1×
reciprocal yield 32.0%
EV / revenue historical average (5Y)
3.4×
reciprocal yield 29.5%
EV / EBIT historical average (3Y)
23.4×
reciprocal yield 4.3%
EV / EBIT historical average (5Y)
28.1×
reciprocal yield 3.6%
EV / EBITDA historical average (3Y)
15.1×
reciprocal yield 6.6%
EV / EBITDA historical average (5Y)
16.8×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-27
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
—
Operating margin
13.0%
Trailing 12 months
Net margin
8.1%
Gross profit (TTM)
—
Operating profit (TTM)
$2.20B
Net income (TTM)
$1.38B
Trailing 12 months
Diluted EPS (TTM)
$8.04
FCF margin
12.9%
Effective tax rate
16.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$99.84
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$12.92
EBITDA per diluted share (TTM)
$19.87
Net income per diluted share (TTM)
$8.06
Operating cash flow per diluted share (TTM)
$16.54
Free cash flow per diluted share (TTM)
$12.81
Capital expenditures per diluted share (TTM)
$3.74
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.62
Book value per share
$37.49

Growth

11 metrics
Revenue growth YoY
+8.7%
Year over year
Net income growth YoY
-3.8%
Revenue (TTM)
$16.98B
Trailing 12 months
EPS growth YoY
-0.6%
Shares change YoY
-3.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.2%
Revenue CAGR (5Y)
+7.5%
EPS CAGR (3Y)
+11.1%
EPS CAGR (5Y)
+40.5%
FCF CAGR (3Y)
+8.9%
FCF CAGR (5Y)
+8.8%

Quality

14 metrics
Return on equity
22.3%
Return on assets
4.6%
Debt / equity
2.6
Current ratio
0.7
EBITDA (TTM)
$3.38B
Free cash flow (TTM)
$2.18B
Quick ratio
0.7
Interest coverage
2.9
Net debt / EBITDA
4.1
Return on invested capital
9.2%
Trailing 12 months
Net cash
−$13.92B
Latest balance sheet
Cash & equivalents
$1.91B
Total assets
$29.88B
Total debt
$16.00B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.82B
Capital expenditures (TTM)
$635.00M
R&D (TTM)
—
SG&A (TTM)
$2.06B
Stock compensation (TTM)
$275.00M
R&D / revenue
—
Stock compensation / revenue
1.6%

Ownership (13F)

9 metrics
13F filers
1,096
13F filer change QoQ
+15
Institutional ownership
94.4%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
25.6%
Private-fund adviser ownership
24.7%
Active holders' share change QoQ
-2.5%
Holder tenure
15.8
Price vs estimated holder cost
+0.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.0%

Short interest

3 metrics
Short interest
1.9%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$29.89M
Insider-sentiment score
9 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1478242 CUSIP 46266C105 13F (30d) 257 filings 234 filers Visit website Investor relations